What's the best ashwagandha in Australia?

JSHealth Ashwagandha+ at AU$45 is The Glow's editor pick for 2026 (Glow Score 9.0). It is the only AU-formulated supplement delivering a clean 600mg of patented KSM-66 at 5% withanolides — the dose used in the Lopresti 2019 trial — and it holds a TGA AUST L listing. Pure Encapsulations Ashwagandha Rhodiola Stress Complex at AU$68 takes second on Glow Score 8.7.

KSM-66 is the patented root-only ashwagandha extract from Ixoreal Biomed, standardised to 5% withanolides. It is the most clinically studied ashwagandha extract on the market — used in more than two dozen human trials. Any AU brand selling KSM-66 has licensed it from Ixoreal; the alternative patent is Sensoril, owned by Natreon.

How much ashwagandha should I take?

600mg/day of standardised KSM-66, in two 300mg doses with meals. This is the protocol from Lopresti et al. 2019 (Medicine, Baltimore), which showed cortisol reduction and DASS-21 improvement at eight weeks. Higher doses do not show better outcomes in the literature.

When will I feel ashwagandha?

Sleep onset improvements are reported at week two to four. Measurable cortisol reduction and DASS-21 stress score changes show at week four to eight. Most non-responders abandon at week six — the panel's read is to hold the dose until at least the eight-week mark before judging it.

Is ashwagandha safe — side effects?

Generally well tolerated. Reported effects are GI upset, drowsiness and vivid dreams. It is contraindicated in pregnancy, active autoimmune flare, and alongside immunosuppressants — it is an immunomodulator. Because it can raise T3 and T4, anyone with thyroid disease should consult their GP before starting.

Is ashwagandha better for sleep or stress?

KSM-66 is the daytime cortisol pick — balanced, mildly energising. Sensoril is the more sedating extract and the panel default for sleep — Nature's Way Sensoril Ashwagandha at AU$30 is the night-time pick. If you want both, take KSM-66 with breakfast and Sensoril after dinner, but check with your GP before stacking.

Is ashwagandha TGA approved?

Ashwagandha is listed on the Australian Register of Therapeutic Goods (ARTG) as a listed medicine — AUST L on the label. JSHealth Ashwagandha+ holds AUST L 437168. Listed medicines are assessed for safety and quality but not for efficacy claims. Imported brands like Pure Encapsulations and Anima Mundi are sold as complementary medicines without an AUST L number.

The Glow Standard · Wellness · Ashwagandha

The ashwagandha that does what it says.

Eleven tested. Four ranked. The one our editors restock is the only one delivering 600mg of patented KSM-66 at a clinical withanolide count.

By Elizabeth Agresta · Elizabeth Agresta, Founder · Updated 3 June 2026

KSM JSHealth · Glow #1

The verdict Winner: JSHealth Ashwagandha+ · Glow 9.0/10 · Read the brand profile →

The verdict

If you only buy one.

Buy JSHealth Ashwagandha+ at AU$45. Glow Score 9.0. It is the only AU-formulated supplement on the shelf delivering a clean 600mg of patented KSM-66 standardised to 5% withanolides — the exact protocol from the Lopresti 2019 trial in Medicine (Baltimore). Anything labelled "ashwagandha extract" without KSM-66 or Sensoril on the bottle, and without a withanolide percentage, is the wrong supplement to spend on. The benchmark to match is 600mg/day for at least eight weeks.

Average Glow Score across 4 ashwagandhas tested: 8.6/10 · 11 tested in total · 6-week panel

The ranking

Four worth the eight-week trial.

Most ashwagandha on Australian shelves is unstandardised root powder with no withanolide figure on the label. These four are the exception — patented extracts or sourcing the panel could verify, at doses that match the trial literature.

JSHealth

Ashwagandha+ KSM-66 600mg

The only AU-formulated supplement on shelf delivering a clean 600mg of patented KSM-66 standardised to 5% withanolides — the same dose used in the Lopresti 2019 trial. The panel reported reliable cortisol-curve flattening by week four and the most consistent sleep onset of the four. TGA AUST L 437168.

Glow Score 9.0AU$45 · 60 capsKSM-66 · 5% withanolides

Buy at Chemist Warehouse

Pure Encapsulations

Ashwagandha Rhodiola Stress Complex

A practitioner-tier stack pairing 250mg KSM-66 with 100mg Rhodiola rosea at 3% rosavins. The lower ashwagandha dose suits anyone titrating up or sensitive to adaptogens. Hypoallergenic capsule, no excipients of note — the formulation our naturopath panellist defaulted to.

Glow Score 8.7AU$68 · 60 capsKSM-66 + Rhodiola

Buy at iHerb

Nature's Way

Sensoril Ashwagandha

Sensoril is the second patented extract — root and leaf, 10% withanolides, distinctly more sedating than KSM-66. Take it at night. The pick if you came to ashwagandha for sleep rather than daytime cortisol. Stocked at Chemist Warehouse for under thirty dollars, which makes it the budget entry.

Glow Score 8.4AU$30 · 60 capsSensoril · 10% withanolides

Buy at Chemist Warehouse

Anima Mundi

Ashwagandha Powder

Loose-root powder, organic, no proprietary extract. Lower potency per gram than a KSM-66 capsule but the format our herbalist panellist trusted — stir a teaspoon into warm oat milk before bed. Buy it for the sourcing and the ritual, not the standardisation. Not TGA listed; imported.

Glow Score 8.2AU$52 · 113gWhole root · unstandardised

Buy at Anima Mundi

How we tested

Six weeks. Six panellists. One protocol.

An ashwagandha earns a spot only if the panel logs a measurable DASS-21 drop and the brand can prove its withanolide content. Founder Elizabeth Agresta signs off the read-out.

Step 01 · Standardisation

A patented extract, or out.

A product cannot rank above 8.0 without a patented standardised extract — KSM-66 or Sensoril — with withanolide content disclosed on the label. Generic "ashwagandha extract" is rejected at the formulation stage. Unstandardised root powder is judged separately on sourcing.

Step 02 · Withanolide content

5% for KSM-66. 10% for Sensoril.

Withanolide percentage is verified against the brand's Certificate of Analysis. KSM-66 must hit 5%; Sensoril 10%. Anything labelled "4:1 extract" without a withanolide figure is treated as unverifiable and scored down on Formulation accordingly.

Step 03 · Dose verification

600mg/day, two divided doses.

The Glow scores against the Lopresti et al. 2019 protocol — 600mg/day standardised KSM-66 split into two 300mg doses with meals. Capsules under 300mg of standardised extract cannot win the category. Sensoril is scored against its own 250mg twice-daily trial benchmark.

Step 04 · Tolerability · DASS-21

Six panellists, eight weeks of logs.

Each ashwagandha was used twice daily for six weeks across six panellists. Panellists logged GI tolerance, drowsiness, dream intensity, and any thyroid-related cues. DASS-21 stress, anxiety and depression scores were collected at week 0 and week 6. Anyone with thyroid disease, autoimmune flare, or on immunosuppressants was excluded.

Step 05 · TGA · AU availability

AUST L or a reliable AU stockist.

Final picks must hold a TGA AUST L listing or be reliably available through an Australian-shipping retailer. No product was scored on label claim alone — every batch was bought retail at the panellist's local chemist or online stockist, then cross-referenced with the brand's published Certificate of Analysis.

Step 06 · Editorial sign-off

Two editors, then Elizabeth.

Final scores were signed off by Founder Elizabeth Agresta after a second-editor read and a check against The Glow's disclosure policy. No paid placement, no affiliate weighting at the scoring stage — the affiliate decision happens after the score is locked.

Field note

The ashwagandha aisle, briefly.

The ashwagandha problem in Australia is a patent problem. KSM-66 — the most studied root extract — is owned by a single Indian manufacturer, Ixoreal Biomed. Sensoril is owned by Natreon. Every credible AU brand selling ashwagandha is licensing one of those two extracts and printing the patent name on the label. Anything that does not name KSM-66 or Sensoril is generic 4:1 or 5:1 extract, which has run almost none of the randomised trials the marketing borrows from.

The dose threshold matters more than the brand. The Lopresti et al. 2019 trial in Medicine (Baltimore) — the one most often quoted in stress-and-cortisol claims — ran 600mg/day of KSM-66 for eight weeks. The follow-ups land in the same window. Anything under 300mg, anything without a withanolide percentage on the label, anything pitched as "a blend" with a hundred milligrams of ashwagandha buried in it: not the same product as the one in the trials. The honest read is that most ashwagandha on Australian shelves is underdosed against the literature it implies.

Channel matters too. Chemist Warehouse and Priceline carry the AU-formulated KSM-66 options — JSHealth, Caruso's, Nature's Way Sensoril — at AUST L pricing. Practitioner brands like Pure Encapsulations and Thorne come through iHerb or a naturopath, generally without an AUST L number, regulated as complementary medicines. The DTC herbalist tier (Anima Mundi, Sun Potion) is whole-root powder at a tea-ceremony price. Each tier has a use; the mistake is treating a practitioner stack and a Chemist Warehouse capsule as interchangeable on the same shelf-talker.

Two things the panel kept coming back to. The first is timing — KSM-66 is daytime, Sensoril is night. The second is patience — most non-responders abandon at week six, exactly when the cortisol literature says the curve starts to move. Hold the dose to eight weeks before judging it. And if you are on thyroid medication, immunosuppressants, or are pregnant, this is a GP conversation before it is a Chemist Warehouse one. The Glow Standard →